Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial

  • Mieke van Schaik
  • , Eline J Arends
  • , Darius Soonawala
  • , Ellen van Ommen
  • , Karina de Leeuw
  • , Maarten Limper
  • , Pieter van Paassen
  • , Tom W J Huizinga
  • , René E M Toes
  • , Cees van Kooten
  • , Joris I Rotmans
  • , Ton J Rabelink
  • , Y K Onno Teng*
    • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Efficacy of belimumab combined with rituximab in severe systemic lupus erythematosus: study protocol for the phase 3, multicenter, randomized, open-label Synbiose 2 trial'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science